Issue 31 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Cancer Crusade tells the gripping story of the National Cancer Act

Summer reading issue 2021: Reflecting on two years of reckoning

What are you reading in 2021?

Books that mattered to me this year

The history—and future—of oncology, according to directors of the first three NCI-designated Comprehensive Cancer Centers
“There couldn’t be a better time to be in oncology”

Midway through the 50th anniversary year of the National Cancer Act, what have we learned?

In Brief

OIG to review FDA’s accelerated approval pathway

Jim Gabriele named president and CEO of M2GEN

Memorial Sloan Kettering establishes MSKCC India

New software to capture worldwide cancer data

Clinical Roundup

Keytruda significantly prolonged RFS compared to placebo as adjuvant therapy in phase III KEYNOTE-716 Trial

International collaboration helps refine treatment for childhood leukemia

Comprehensive clinical sequencing opens door to the promise of precision medicine

Statins may improve survival for triple-negative breast cancer patients

Drugs & Targets

Opdivo receives EC approval in Esophageal/GEJ indication

FDA grants Priority Review to Tecentriq as adjuvant treatment in NSCLC indication

Cabometyx sNDA receives FDA priority review for previously treated radioactive iodine-refractory differentiated thyroid cancer

BMS issues statement on Istodax relapsed/refractory peripheral T-cell lymphoma U.S. indication

NCI Trials

NCI Trials for August 2021

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login